These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 31198046)

  • 21. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization, and in vitro anti-tumor activity studies of the hyaluronic acid-mangiferin-methotrexate nanodrug targeted delivery system.
    Wang H; Shao W; Lu X; Gao C; Fang L; Yang X; Zhu P
    Int J Biol Macromol; 2023 Jun; 239():124208. PubMed ID: 36972827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronic Acid-Methotrexate Conjugates Coated Magnetic Polydopamine Nanoparticles for Multimodal Imaging-Guided Multistage Targeted Chemo-Photothermal Therapy.
    Li Q; Chen Y; Zhou X; Chen D; Li Y; Yang J; Zhu X
    Mol Pharm; 2018 Sep; 15(9):4049-4062. PubMed ID: 30011996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, characterization and in vitro antitumor activity evaluation of hyaluronic acid-alendronate-methotrexate nanoparticles.
    Gao C; Wang M; Zhu P; Yan C
    Int J Biol Macromol; 2021 Jan; 166():71-79. PubMed ID: 33091477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
    Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
    Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
    Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
    Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.
    Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z
    ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
    J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy.
    Tan R; Tian D; Liu J; Wang C; Wan Y
    Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox sensitive nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine conjugates for CD44-targeted delivery of hydroxychloroquine to combat breast cancer metastasis in vitro and in vivo.
    He Y; Xu Y; Huang Y; Quang H; Xia X; Zhao H; Xiao Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2022 Feb; 210():112249. PubMed ID: 34864404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.